The Use of Continuous Milrinone Therapy as Bridge to Transplant Is Safe in Patients With Short Waiting Times Academic Article uri icon

Overview

MeSH Major

  • Heart Transplantation
  • Milrinone
  • Waiting Lists

abstract

  • This study suggests that chronic intravenous milrinone provides an adequate strategy as a bridge to transplant if the waiting time is short (<100 days), whereas an elective ventricular assist device implantation may be a safer strategy for patients expected to wait longer. These data provide the basis for a prospective evaluation of inotrope versus LVAD as a bridge to transplantation.

publication date

  • December 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.cardfail.2008.08.004

PubMed ID

  • 19041047

Additional Document Info

start page

  • 839

end page

  • 43

volume

  • 14

number

  • 10